Pharma/Biotech - Page 1 | TalkMarkets
All Posts > Content under Pharma/Biotech
1 to 16 of 2534 Posts
1 2 3 ... 159
Week In Review: Mevion Medical Of Boston Closes $150 Million Financing From China Investors
Article By: ChinaBio® Today
Saturday, June 16, 2018 4:07 PM EDT
Mevion Medical Systems, a Boston area maker of proton therapy machines, closed a $150 million financing led by YuanMing Capital with participation by other China-based private equity investors.
In this article: APTO, BMY, TTPH
Consumer Discretionary Overtakes Tech As Sector Leader In 2018
Article By: James Picerno
Friday, June 15, 2018 9:25 AM EDT
Consumer discretionary stocks are now the top-performing sector year to date, based on a set of exchange-traded funds through yesterday’s close (June 14).
5 Of Thursday's Biggest Marijuana Stock Losers
Article By: The Daily Marijuana Observer
Friday, June 15, 2018 12:35 AM EDT
Here are five of the biggest marijuana stock losers in trading on Thursday, June 14th.
In this article: CVSI, MCGI, MRRCF, CNNRF, SPLIF Also: ACBFF
Drug Stocks: The Next Hot Industry Or Value Traps?
Podcast By: Tracey Ryniec
Thursday, June 14, 2018 8:28 AM EDT
Retail and energy stocks were hated over the last several years too but have staged big turnarounds in 2018. Will the drug stocks be the next big turnaround success story?
In this podcast: VRX, LCI, BIIB, CELG, GILD
5 Of Today's Biggest Marijuana Stock Losers - Tuesday, June 12
Article By: The Daily Marijuana Observer
Tuesday, June 12, 2018 11:21 PM EDT
Here are just 5 of the biggest marijuana stock losers in trading on Tuesday, June 12th.
In this article: CVSI, CANN, CNTTF, IMLFF, MYMMF
3 Biotechs With Upcoming Data To Be Presented At Conferences
Article By: Scott Matusow
Tuesday, June 12, 2018 5:24 AM EDT
Biotech stocks tend to have strong movement when their respective companies have binary events upcoming in short order. Here are 3 companies with upcoming data to be presented at data conferences this week.
In this article: CYTK, ARQL, AFMD Also: MYOK, AZN
5 Of Today's Biggest Marijuana Stock Losers - Monday, June 11
Article By: The Daily Marijuana Observer
Tuesday, June 12, 2018 12:16 AM EDT
Here are five of the biggest marijuana stock losers in trading on Monday, June 11th.
Verrica Pharmaceuticals - Biopharmaceutical Firm Hopes To Raise $75 Million In IPO
Article By: TickerTV
Monday, June 11, 2018 11:53 AM EDT
Verrica Pharmaceuticals – a biopharmaceutical firm that focuses on identifying, developing and commercializing innovative solutions to unmet needs in medical dermatology – is going public on Wednesday, June 14, 2018.
In this article: VRCA
E 3 Marijuana Stocks That Benefit From A Florida Judge's Recent Ruling
Article By: The Daily Marijuana Observer
Monday, June 11, 2018 11:00 AM EDT
Leon County circuit court Judge Karen Gievers upheld her ruling that Florida Legislature's provision banning smokeable medicinal marijuana is unconstitutional. While this process could take months, a few public pot stocks stand to gain from this.
In this article: ITHUF, APHQF
This Cannabis Stock Broke Out Last Week On Monster Volume
Article By: Justin Smyth
Monday, June 11, 2018 10:57 AM EDT
Cronos Group had a big week last week moving higher on almost 40 million shares traded for the week.
In this article: CRON
E Stock Of The Week - Abiomed
Video By: Dr. Joseph Belmonte
Sunday, June 10, 2018 10:51 AM EDT
The stock of the week isn't a big company but it is promising. Abiomed is a company increasing earnings at an increasing rate that makes devices that help our hearts.
In this video: ABMD
Week In Review: Hua Medicine Approved For $200 Million Hong Kong IPO
Article By: ChinaBio® Today
Saturday, June 9, 2018 4:46 PM EDT
Hua Medicine, a Beijing biopharma, announced its IPO application was accepted by the Hong Kong exchange. According to rumors, the company hopes to raise $200 million in the offering.
In this article: BPMC
ADMA Biologics Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Saturday, June 9, 2018 2:00 AM EDT
ADMA Biologics, Inc. announced today the pricing of its previously announced underwritten public offering of 8,368,200 shares of its common stock at a public offering price of $4.78 per share.
In this article: ADMA
3 Biotech Stocks Up In The Past Month On Industry Turnaround
Article By: Zacks Investment Research
Tuesday, June 5, 2018 1:08 PM EDT
After a strong start in 2018, the drug sector struggled a bit in the next few months probably on U.S. market instability and a few negative updates on the pipeline and regulatory front.
In this article: BMRN, LGND, VVUS Also: JNJ
Key FDA Events In June Investors Need To Watch Out For
Article By: Zacks Investment Research
Sunday, June 3, 2018 12:49 PM EDT
It has been a busy year for the FDA so far with the agency approving 14 drugs. The approval of these drugs should boost their respective companies’ top line as a few of them are struggling with decline in sales of legacy drugs.
In this article: MRK, VRX, ARRY, GWPH, ALKS, AKAO
E Penalties And Pardons
Article By: Vivian Lewis
Sunday, June 3, 2018 10:32 AM EDT
President Trump went ahead and raised the steel and aluminum tariffs on Canada and Mexico and European countries despite the fact that they are our allies. He alleges that they are acting as conduits for underpriced Chinese metals.
1 to 16 of 2534 Posts
1 2 3 ... 159